# Changzhou Yabang-QH Pharmachem Co., Ltd. – FDA 483, Jul 24, 2026

Source: https://www.keypedia.com/records/483/changzhou-yabang-qh-pharmachem-co-ltd/fbe5a1cb-4769-4e92-8774-cbe238411ec5

> FDA 483 for Changzhou Yabang-QH Pharmachem Co., Ltd. on July 24, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Changzhou Yabang-QH Pharmachem Co., Ltd.
- Inspection Date: 2026-07-24
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: Changzhou Yabang-QH Pharmachem Co. Ltd., an API manufacturer in Changzhou, China, received three observations during an FDA inspection. The findings include concerns regarding data integrity in their chromatography data system, inadequate evaluation of chemical migration and spillage in their warehouse, and a lack of assessment for potential microbiological or chemical contaminant buildup during consecutive batch manufacturing campaigns. These issues indicate potential deficiencies in quality control and manufacturing practices.

## Related Officers

- [Adetutu M. Gidado](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)
- [Adetunji Gidado](https://www.keypedia.com/people/adetunji-gidado/7ec85406-32c0-4cc3-93b6-f5193b1756b4)

Company: https://www.keypedia.com/companies/changzhou-yabang-qh-pharmachem-co-ltd/459d2ea6-e113-4a49-a58a-93cb974ac367

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8